SCHEMBL8784108

SCHEMBL8784108

Cc1nccn1-c1ccc2[nH]cc(C3CCN(C)C3)c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 3/20 0.58
GABRD O14764 3/20 0.58
GABRA1 P14867 3/20 0.58
GABRB1 P18505 3/20 0.58
GABRG2 P18507 3/20 0.58
GABRB3 P28472 3/20 0.58
GABRA5 P31644 3/20 0.58
GABRA3 P34903 3/20 0.58
GABRA2 P47869 3/20 0.58
GABRB2 P47870 3/20 0.58
GABRA4 P48169 3/20 0.58
GABRE P78334 3/20 0.58
GABRA6 Q16445 3/20 0.58
GABRG1 Q8N1C3 3/20 0.58
GABRG3 Q99928 3/20 0.58
GABRQ Q9UN88 3/20 0.58
KDM4E B2RXH2 1/20 0.54
ATM Q13315 1/20 0.54
HTR1A P08908 2/20 0.50
HTR2C P28335 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8783611 0.94 HTR1D (0.57) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8784148 0.84 GABRP (0.63) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8784268 0.83 OPRM1 (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8783749 0.82 GABRP (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8784342 0.81 HTR1A (0.53) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8784982 0.80 OPRM1 (0.62) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8784524 0.80 KDM4E (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8783956 0.80 KDM4E (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8572226 0.79 KDM4E (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8574883 0.79 KDM4E (0.60) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497512-B1 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME (GB) 1997-09-24 EP claimed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 EP claimed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 EP claimed
EP-0497512-B1 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME (GB) 1997-09-24 EP disclosed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 EP disclosed
US-5602163-A SELECTIVE AGONISTS OF 5-HYDROXYTRYPTAMINE RECEPTORS; USEFUL IN TREATMENT OF MIGRAINE HEADACHES MERCK, SHARP & DOHME LTD. (GB) 1997-02-11 US disclosed
US-5602162-A TREATMENT AND/OR PREVENTION OF MIGRAINE MERCK, SHARP & DOHME LTD. (GB) 1997-02-11 US disclosed
US-5451588-A Treatment of migraines MERCK SHARP & DOHME LTD. (GB) 1995-09-19 US disclosed
US-5298520-A Triazole containing indole derivatives MERCK SHARP & DOHME LIMITED (GB) 1994-03-29 US disclosed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 EP disclosed